D21. Translational Covid-19 Studies 2023
DOI: 10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a6298
|View full text |Cite
|
Sign up to set email alerts
|

Mepolizumab Reduces Clinically Significant Exacerbations in Patients With Severe Asthma Prior to and During the COVID-19 Pandemic: Results From the Real-world REALITI-A Study

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles